Author:
Vogel V.,Häse C.,Baykut D.,Mäntele W.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery
Reference14 articles.
1. Harenberg J, Fenyvesy T (2004) Heparine, Thrombin- und Faktor-Xa-Inhibitoren. Hämostaseologie 4:261–278
2. Koerber JM, Smythe MA, Begle RL, Mattson MD, Kershaw BP, Westley MT (1999) Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration. Pharmacotherapy 19:922–931
3. Haas S, Haas P (1999) Niedermolekulare Heparine – Die Anwendung in Klinik und Praxis Zett, Steinen
4. Hardy JF, Bélisle S, Robitaille D, Perrault J, Roy M, Gagnon L (1996) Measurement of heparine concentration in whole blood with the Hepcon/HMS device does not agree with laboratory determination of plasma heparin concentration using a chromogenic substrate for activated factor X. J Thorac Cardiovasc Surg 112:154–161
5. Linkins LA, Julian JA, Rischke J, Hirsh J, Weitz JI (2002) In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. Thrombosis Research 107:241–244
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献